Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 12:42 pm Purchase | 2025-12-31 | 13G | PTC Therapeutics, Inc. PTCT | JANUS HENDERSON GROUP PLC JHG | 4,851,332 6.000% | 2,824,190 (+139.32%) | Filing History |
| 2026-02-13 1:02 pm Purchase | 2025-12-31 | 13G | PTC Therapeutics, Inc. PTCT | TORONTO DOMINION BANK | 4,138,215 5.200% | 4,138,215 (New Position) | Filing History |
| 2026-02-10 11:21 am Sale | 2025-12-31 | 13G | PTC Therapeutics, Inc. PTCT | WELLINGTON MANAGEMENT GROUP LLP | 3,867,380 4.800% | -919,743 (-19.21%) | Filing History |
| 2026-02-09 07:59 am Purchase | 2025-12-31 | 13G | PTC Therapeutics, Inc. PTCT | STATE STREET CORP STT | 4,206,126 5.200% | 1,307,086 (+45.09%) | Filing History |
| 2025-12-04 2:24 pm Purchase | 2025-11-30 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 11,904,696 14.800% | 5,630,312 (+89.73%) | Filing History |
| 2025-11-14 6:20 pm Sale | 2025-09-30 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 3,277,272 4.080% | -1,458,192 (-30.79%) | Filing History |
| 2025-10-30 3:49 pm Sale | 2025-09-30 | 13G | PTC Therapeutics, Inc. PTCT | The Vanguard Group | 8,288,999 10.430% | -511,844 (-5.82%) | Filing History |
| 2025-08-14 9:42 pm Purchase | 2025-06-30 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 4,735,464 5.960% | 4,735,464 (New Position) | Filing History |
| 2025-05-15 3:46 pm Sale | 2025-03-31 | 13G | PTC Therapeutics, Inc. PTCT | Armistice Capital, LLC | 5,434,843 6.860% | -943,157 (-14.79%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 6,274,384 8.000% | -1,394,487 (-18.18%) | Filing History |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | Armistice Capital, LLC | 6,378,000 8.270% | -856,898 (-11.84%) | Filing History |
| 2025-02-14 08:35 am Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | Camber Capital Management LP | 3,200,000 4.150% | -800,000 (-20.00%) | Filing History |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | WELLINGTON MANAGEMENT GROUP LLP | 4,787,123 6.200% | -3,105,676 (-39.35%) | Filing History |
| 2024-11-14 5:22 pm Purchase | 2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT | Armistice Capital, LLC | 7,234,898 9.400% | 370,898 (+5.40%) | Filing History |
| 2024-11-08 10:52 am Sale | 2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT | WELLINGTON MANAGEMENT GROUP LLP | 7,892,799 10.260% | -1,923,804 (-19.60%) | Filing History |
| 2024-10-18 10:57 am Sale | 2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT | STATE STREET CORP STT | 2,899,040 3.800% | -1,734,915 (-37.44%) | Filing History |
| 2024-08-27 4:45 pm Sale | 2024-08-23 | 13D | MRI INTERVENTIONS INC MRIC | PTC THERAPEUTICS INC. PTCT | 894,578 3.240% | -1,666,667 (-65.07%) | Filing History |
| 2024-02-14 3:50 pm Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | Armistice Capital, LLC | 6,864,000 9.100% | 6,864,000 (New Position) | Filing History |
| 2024-02-14 07:13 am Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | RTW Investments, LP | 7,423,970 9.800% | 1,808,583 (+32.21%) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | PTC Therapeutics, Inc. PTCT | The Vanguard Group | 8,800,843 11.660% | 1,461,323 (+19.91%) | Filing History |